TREXIOCEL
Live / Applied — Non-final action mailed (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 24 Oct 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99461793
- Mark type
- Stylized text
- Filed
- 24 Oct 2025
- Attorney of record
- SEAN KENNETH OWENS
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products in the nature of pharmaceutical preparations for the treatment, alleviation and healing of peripheral arterial diseases and wounds including peripheral arterial shutter-illness and diabetic foot ulcers; pharmaceutical products in the nature of pharmaceutical preparations for tissue repair and tissue regeneration
- Class 042 — Scientific and technological services: Development of pharmaceutical preparations and substances in the nature of medicines; scientific and technological services in the nature of analysis and research in the field of pharmaceuticals; industrial analysis and research services, namely, industrial research in the field of pharmaceuticals and scientific and technological analysis in the field of pharmaceuticals
- Class 044 — Medical, beauty and agricultural services: Medical services
Owner
- RHEACELL GmbH & Co. KG, Heidelberg, DE
Prosecution history
- 12 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 12 Mar 2026 — NON-FINAL ACTION E-MAILED
- 12 Mar 2026 — NON-FINAL ACTION WRITTEN
- 11 Mar 2026 — ASSIGNED TO EXAMINER
- 11 Feb 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 24 Oct 2025 — APPLICATION FILING RECEIPT MAILED
- 24 Oct 2025 — NEW APPLICATION ENTERED